CLEAR Thrombectomy Score: An Index to Estimate the Probability of Good Functional Outcome With or Without Endovascular Treatment in the Late Window for Anterior Circulation Occlusion.

acute stroke endovascular therapy late window prognosis score thrombectomy

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
09 Jul 2024
Historique:
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 9 7 2024
Statut: aheadofprint

Résumé

With the expanding eligibility for endovascular therapy (EVT) of patients presenting in the late window (6-24 hours after last known well), we aimed to derive a score to predict favorable outcomes associated with EVT versus best medical management. A multinational observational cohort of patients from the CLEAR (Computed Tomography for Late Endovascular Reperfusion) study with proximal intracranial occlusion (2014-2022) was queried (n=58 sites). Logistic regression analyses were used to derive a 9-point score for predicting good functional outcome (modified Rankin Scale score 0-2 or return to premorbid modified Rankin Scale score) at 90 days, with sensitivity analyses for prespecified subgroups conducted using bootstrapped random forest regressions. Secondary outcomes included 90-day functional independence (modified Rankin Scale score 0-2), poor outcome (modified Rankin Scale score 5-6), and 90-day survival. The score was externally validated with a single-center cohort (2014-2023). Of the 3231 included patients (n=2499 EVT), a 9-point score included age, early computed tomography ischemic changes, and stroke severity, with higher points indicating a higher probability of a good functional outcome. The areas under the curve for the primary outcome among EVT and best medical management subgroups were 0.72 (95% CI, 0.70-0.74) and 0.87 (95% CI, 0.84-0.90), respectively, with similar performance in the external validation cohort (area under the curve, 0.71 [95% CI, 0.66-0.76]). There was a significant interaction between the score and EVT for good functional outcome, functional independence, and poor outcome (all This score is a pragmatic tool that can estimate the probability of a good outcome with EVT in the late window. URL: https://www.Clinicaltrials.gov; Unique identifier: NCT04096248.

Sections du résumé

BACKGROUND BACKGROUND
With the expanding eligibility for endovascular therapy (EVT) of patients presenting in the late window (6-24 hours after last known well), we aimed to derive a score to predict favorable outcomes associated with EVT versus best medical management.
METHODS AND RESULTS RESULTS
A multinational observational cohort of patients from the CLEAR (Computed Tomography for Late Endovascular Reperfusion) study with proximal intracranial occlusion (2014-2022) was queried (n=58 sites). Logistic regression analyses were used to derive a 9-point score for predicting good functional outcome (modified Rankin Scale score 0-2 or return to premorbid modified Rankin Scale score) at 90 days, with sensitivity analyses for prespecified subgroups conducted using bootstrapped random forest regressions. Secondary outcomes included 90-day functional independence (modified Rankin Scale score 0-2), poor outcome (modified Rankin Scale score 5-6), and 90-day survival. The score was externally validated with a single-center cohort (2014-2023). Of the 3231 included patients (n=2499 EVT), a 9-point score included age, early computed tomography ischemic changes, and stroke severity, with higher points indicating a higher probability of a good functional outcome. The areas under the curve for the primary outcome among EVT and best medical management subgroups were 0.72 (95% CI, 0.70-0.74) and 0.87 (95% CI, 0.84-0.90), respectively, with similar performance in the external validation cohort (area under the curve, 0.71 [95% CI, 0.66-0.76]). There was a significant interaction between the score and EVT for good functional outcome, functional independence, and poor outcome (all
CONCLUSIONS CONCLUSIONS
This score is a pragmatic tool that can estimate the probability of a good outcome with EVT in the late window.
REGISTRATION BACKGROUND
URL: https://www.Clinicaltrials.gov; Unique identifier: NCT04096248.

Identifiants

pubmed: 38979812
doi: 10.1161/JAHA.124.034948
doi:

Banques de données

ClinicalTrials.gov
['NCT04096248']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034948

Auteurs

James E Siegler (JE)

University of Chicago Medical Center Chicago IL USA.

Manisha Koneru (M)

Cooper Medical School of Rowan University Camden NJ USA.

Muhammad M Qureshi (MM)

Radiology, Radiation Oncology Boston Medical Center Boston MA USA.

Mohamed Doheim (M)

University of Pittsburgh Medical Center Pittsburgh PA USA.

Raul G Nogueira (RG)

University of Pittsburgh Medical Center Pittsburgh PA USA.

Nicolas Martinez-Majander (N)

Neurology, Helsinki University Hospital Helsinki Finland.

Simon Nagel (S)

Neurology Klinikum Ludwigshafen Ludwigshafen Germany.
Neurology Heidelberg University Hospital Heidelberg Germany.

Mary Penckofer (M)

Cooper Medical School of Rowan University Camden NJ USA.

Jelle Demeestere (J)

Neurology Leuven University Hospital Leuven Belgium.
Laboratory for Neurobiology KU Leuven Leuven Belgium.

Volker Puetz (V)

Neurology University Hospital Carl Gustav Carus Dresden Germany.
Dresden Neurovascular Center University Hospital Carl Gustav Carus Dresden Germany.

Marc Ribo (M)

Neurology Hospital Vall d'Hebron Barcelona Spain.

Mohamad Abdalkader (M)

Radiology Boston Medical Center Boston MA USA.

João Pedro Marto (JP)

Neurology Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental Lisbon Portugal.

Alhamza R Al-Bayati (AR)

University of Pittsburgh Medical Center Pittsburgh PA USA.

Hiroshi Yamagami (H)

Stroke Prevention and Treatment Institute of Medicine, University of Tsukuba Japan.

Diogo C Haussen (DC)

Neurology Grady Memorial Hospital Atlanta GA USA.

Marta Olive-Gadea (M)

Neurology Hospital Vall d'Hebron Barcelona Spain.

Simon Winzer (S)

Neurology University Hospital Carl Gustav Carus Dresden Germany.
Dresden Neurovascular Center University Hospital Carl Gustav Carus Dresden Germany.

Mahmoud H Mohammaden (MH)

Neurology Grady Memorial Hospital Atlanta GA USA.

Robin Lemmens (R)

Neurology Leuven University Hospital Leuven Belgium.
Laboratory for Neurobiology KU Leuven Leuven Belgium.

Kanta Tanaka (K)

Division of Stroke Care Unit National Cerebral and Cardiovascular Center Suita Japan.

Pekka Virtanen (P)

Radiology Helsinki University Hospital Helsinki Finland.

Anne Dusart (A)

Neurology Hôpital Civil Marie Curie Charleroi Belgium.

Flavio Bellante (F)

Neurology Hôpital Civil Marie Curie Charleroi Belgium.

Daniel P O Kaiser (DPO)

Dresden Neurovascular Center University Hospital Carl Gustav Carus Dresden Germany.
Institute of Neuroradiology University Hospital Carl Gustav Carus Dresden Germany.

Francois Caparros (F)

Neurology Centre Hospitalier Universitaire de Lille Lille France.

Hilde Henon (H)

Neurology Centre Hospitalier Universitaire de Lille Lille France.

João Nuno Ramos (JN)

Neuroradiology Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental Lisbon Portugal.

Santiago Ortega-Gutierrez (S)

Neurology University of Iowa Hospitals and Clinics Iowa City IA USA.

Sunil A Sheth (SA)

Neurology UTHealth McGovern Medical School Houston TX USA.

Stefania Nannoni (S)

Clinical Neurosciences University of Cambridge Cambridge UK.

Lieselotte Vandewalle (L)

Neurology Leuven University Hospital Leuven Belgium.
Laboratory for Neurobiology KU Leuven Leuven Belgium.

Johannes Kaesmacher (J)

Institute of Diagnostic and Interventional Neuroradiology University Hospital Bern Bern Switzerland.

Sergio Salazar-Marioni (S)

Neurology UTHealth McGovern Medical School Houston TX USA.

Liisa Tomppo (L)

Neurology, Helsinki University Hospital Helsinki Finland.

Rita Ventura (R)

Neurology Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental Lisbon Portugal.

Syed F Zaidi (SF)

Neurology University of Toledo Toledo OH USA.

Mouhammad Jumaa (M)

Neurology University of Toledo Toledo OH USA.

Alicia C Castonguay (AC)

Neurology University of Toledo Toledo OH USA.

Milagros Galecio-Castillo (M)

Neurology University of Iowa Hospitals and Clinics Iowa City IA USA.

Ajit S Puri (AS)

Interventional Neuroradiology University of Massachusetts Memorial Medical Center Worcester MA USA.

Adnan Mujanovic (A)

Institute of Diagnostic and Interventional Neuroradiology University Hospital Bern Bern Switzerland.

Piers Klein (P)

Radiology Boston Medical Center Boston MA USA.

Liqi Shu (L)

Neurology Rhode Island Hospital, Brown University Providence RI USA.

Behzad Farzin (B)

Radiology Centre Hospitalier de l'Université de Montréal Montreal QC Canada.

Hannah Moomey (H)

Radiology Boston Medical Center Boston MA USA.

Hesham E Masoud (HE)

Neurology State University of New York Syracuse NY USA.

Jessica Jesser (J)

Neuroradiology Heidelberg University Hospital Heidelberg Germany.

Markus A Möhlenbruch (MA)

Neuroradiology Heidelberg University Hospital Heidelberg Germany.

Peter A Ringleb (PA)

Neurology Heidelberg University Hospital Heidelberg Germany.

Daniel Strbian (D)

Neurology, Helsinki University Hospital Helsinki Finland.

Osama O Zaidat (OO)

Neuroscience and Stroke Program Bon Secours Mercy Health St. Vincent Hospital Toledo OH USA.

Shadi Yaghi (S)

Neurology Rhode Island Hospital, Brown University Providence RI USA.

Davide Strambo (D)

Neurology Service Lausanne University Hospital and University of Lausanne Lausanne Switzerland.

Patrik Michel (P)

Neurology Service Lausanne University Hospital and University of Lausanne Lausanne Switzerland.

Daniel Roy (D)

Radiology Centre Hospitalier de l'Université de Montréal Montreal QC Canada.

Shinichi Yoshimura (S)

Neurosurgery Hyogo Medical University Nishinomiya Japan.

Kazutaka Uchida (K)

Neurosurgery Hyogo Medical University Nishinomiya Japan.

Jean Raymond (J)

Radiology Centre Hospitalier de l'Université de Montréal Montreal QC Canada.

Thanh N Nguyen (TN)

Radiology Boston Medical Center Boston MA USA.
Neurology Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine Boston MA USA.

Classifications MeSH